ADHD Trial, Recruiting (NCT07466147)

ADHD Trial, Recruiting NCT07466147 Sponsor: University of Tartu Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT07466147 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is between 5 and 12 years old
The child has been diagnosed with or is experiencing ADHD, autism spectrum disorder (ASD), difficulties managing behaviour, and/or difficulties fitting in or adapting in group settings
The child is currently receiving physiotherapy at ProVida Clinic, or has been assessed by the clinic's rehabilitation team to check if participation is appropriate
The child is able to take part in movement-based and play-based activities in a group setting
The child can understand and communicate in Estonian
The child has not previously taken part in a similar group programme

Who may not be able to join:

The child has a current or ongoing medical condition that would prevent them from actively taking part
The child has significant cognitive (thinking or learning) or sensory difficulties that would make it hard for them to understand the activities or participate safely (confirm with trial site)
There are specific circumstances where the child's involvement could disrupt the group or raise safety concerns (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +37258361041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07466147

Sponsor: University of Tartu

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: +37258361041

More information: https://clinicaltrials.gov/study/NCT07466147

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is between 5 and 12 years old
The child has been diagnosed with or is experiencing ADHD, autism spectrum disorder (ASD), difficulties managing behaviour, and/or difficulties fitting in or adapting in group settings
The child is currently receiving physiotherapy at ProVida Clinic, or has been assessed by the clinic's rehabilitation team to check if participation is appropriate
The child is able to take part in movement-based and play-based activities in a group setting
The child can understand and communicate in Estonian
The child has not previously taken part in a similar group programme

Who may not be able to join:

The child has a current or ongoing medical condition that would prevent them from actively taking part
The child has significant cognitive (thinking or learning) or sensory difficulties that would make it hard for them to understand the activities or participate safely (confirm with trial site)
There are specific circumstances where the child's involvement could disrupt the group or raise safety concerns (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Tartu

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

1 February 2027

Where this trial is recruiting

🇪🇪 Estonia

Primary endpoints

Quality of life of the participants; Positive and negative aspects of psychosocial functioning of the participants

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov